AbstractHigh throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing (WES) create an unprecedented amount of data providing powerful resources for clinical care and research. Recently, WGS and WES services have been made available by commercial direct-to-consumer (DTC) companies. The DTC offer of genetic testing (GT) has already brought attention to potentially problematic issues such as the adequacy of consumers' informed consent and transparency of companies' research activities. In this study, we analysed the websites of four DTC GT companies offering WGS and/or WES with regard to their policies governing storage and future use of consumers' data and samples. The results are discussed in relation to recomme...
We explored the characteristics and motivations of people who, having obtained their genetic or geno...
We explored the characteristics and motivations of people who, having obtained their genetic or geno...
Abstract Background Large-scale whole genome sequencing (WGS) studies promise to revolutionize cance...
High throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing (WES) cr...
High throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing (WES) cr...
AbstractHigh throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing ...
Whole exome sequencing (WES) and whole genome sequencing (WGS) have become increasingly available in...
In the wake of recent regulations targeting direct-to-consumer genetic testing (DTC-GT), an increasi...
Broad genome-wide testing is increasingly finding its way to the public through the online direct-to...
Personal genomic data and the related health data are valuable resources for both public-funded rese...
Whole genome and exome sequencing (WGS and WES) raise numerous ethical, legal and social issues (ELS...
Personal genomic data and the related health data are valuable resources for both public-funded rese...
In the last decade, the cost of sequencing the human genome has dropped significantly, enabling the ...
Numerous direct-to-consumer genetic testing services now offer individuals genetic sequencing, testi...
We explored the characteristics and motivations of people who, having obtained their genetic or geno...
We explored the characteristics and motivations of people who, having obtained their genetic or geno...
Abstract Background Large-scale whole genome sequencing (WGS) studies promise to revolutionize cance...
High throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing (WES) cr...
High throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing (WES) cr...
AbstractHigh throughput approaches such as whole genome sequencing (WGS) and whole exome sequencing ...
Whole exome sequencing (WES) and whole genome sequencing (WGS) have become increasingly available in...
In the wake of recent regulations targeting direct-to-consumer genetic testing (DTC-GT), an increasi...
Broad genome-wide testing is increasingly finding its way to the public through the online direct-to...
Personal genomic data and the related health data are valuable resources for both public-funded rese...
Whole genome and exome sequencing (WGS and WES) raise numerous ethical, legal and social issues (ELS...
Personal genomic data and the related health data are valuable resources for both public-funded rese...
In the last decade, the cost of sequencing the human genome has dropped significantly, enabling the ...
Numerous direct-to-consumer genetic testing services now offer individuals genetic sequencing, testi...
We explored the characteristics and motivations of people who, having obtained their genetic or geno...
We explored the characteristics and motivations of people who, having obtained their genetic or geno...
Abstract Background Large-scale whole genome sequencing (WGS) studies promise to revolutionize cance...